|
The study - one of the largest genetic studies ever done in this field, involving 40,000 people from eight European countries - was conducted as part of the InGenious HyperCare Project, an EU-funded international collaboration.
One adult in four in the EU suffers from the condition which, as the most important cardio-vascular risk factor, is ultimately the leading cause of death worldwide. Individuals carrying the new variant were found to have 15% fewer strokes, myocardial infarctions and coronary deaths.
More front page news
|